PaxlovidTM – Making an Informed Decision

Canadian Covid Care Alliance

In January 2022, Health Canada approved the use of the oral antiviral medication called PAXLOVIDTM. PAXLOVIDTM is made of a combination of two medications: nirmatrelvir and ritonavir.

As with any medication, there are a number of key questions that healthcare practitioners can and do use to help determine if it is a good choice for their patients. We felt it important to offer the public the same kind of review, especially since this is a new medication.

Latest articles

Miranda Castro Schüssler investigated the chemical make-up of human cells and found...
Craig Paardekooper An FOIA request by Judicial Watch led to the disclosure...
Dobrin Draganov et al. Ivermectin converts cold tumors hot and synergizes with...
Technocracy News Digital identity, digital twins, programmable central bank digital currency, a...
Aaron Kheriaty Unless we collectively decline to participate in this new social...

Thank you!

Thank you for your membership application. As soon as your payment has been received your membership will be activated and you will be informed via email.

Thank you.

Thank you!

The form has been submitted successfully!